A team of outside experts has been taking steps to help Impax Laboratories get back on track after manufacturing issues sidetracked a key drug application and a key partnership with GlaxoSmithKline ($GSK). The company earlier this month said it would lay off 10% of its workforce to save money and now it says co-founder and CEO Larry Hsu is stepping down to make room for new leadership.
Read more: Impax to get new CEO as it tries to right manufacturing issues - FiercePharma Manufacturing http://www.fiercepharmamanufacturing.com/story/impax-get-new-ceo-it-tries-right-manufacturing-issues/2013-06-25#ixzz2XKhkCV1Q
Subscribe at FiercePharma Manufacturing
